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Abstract
Background
Expanding public health insurance seeks to attain several desirable objectives, including
increasing access to healthcare services, reducing the risk of catastrophic healthcare
expenditures, and improving health outcomes. The extent to which these objectives are met
in a real-world policy context remains an empirical question of increasing research and pol-
icy interest in recent years.
Methods
We reviewed systematically empirical studies published from July 2010 to September 2016
using Medline, Embase, Econlit, CINAHL Plus via EBSCO, and Web of Science and grey lit-
erature databases. No language restrictions were applied. Our focus was on both rando-
mised and observational studies, particularly those including explicitly attempts to tackle
selection bias in estimating the treatment effect of health insurance. The main outcomes
are: (1) utilisation of health services, (2) financial protection for the target population, and (3)
changes in health status.
Findings
8755 abstracts and 118 full-text articles were assessed. Sixty-eight studies met the inclusion
criteria including six randomised studies, reflecting a substantial increase in the quantity and
quality of research output compared to the time period before 2010. Overall, health insur-
ance schemes in low- and middle-income countries (LMICs) have been found to improve
access to health care as measured by increased utilisation of health care facilities (32 out of
40 studies). There also appeared to be a favourable effect on financial protection (26 out of
46 studies), although several studies indicated otherwise. There is moderate evidence that
health insurance schemes improve the health of the insured (9 out of 12 studies).
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Interpretation
Increased health insurance coverage generally appears to increase access to health care
facilities, improve financial protection and improve health status, although findings are not
totally consistent. Understanding the drivers of differences in the outcomes of insurance
reforms is critical to inform future implementations of publicly funded health insurance to
achieve the broader goal of universal health coverage.
Introduction
In recent decades, achieving universal health coverage (UHC) has been a major health policy
focus globally.[1–3] UHC entitles all people to access healthcare services through publicly
organised risk pooling,[4] safeguarding against the risk of catastrophic healthcare expendi-
tures.[5] Low- and middle-income countries (LMICs) face particular challenges in achieving
UHC due to particularly limited public resources for health care, inefficient allocation, over-
reliance on out-of-pocket payments, and often large population size.[5] As a result, access to
health care and the burden of financial cost in LMICs tends to be worse for the poor, often
resulting in forgone care.[6–8]
Introducing and increasing the coverage of publicly organised and financed health insur-
ance is widely seen as the most promising way of achieving UHC,[9,10] since private insurance
is mostly unaffordable for the poor.[11] Historically, social health insurance, tax-based insur-
ance, or a mix of the two have been the dominant health insurance models amongst high
income countries and some LMICs, including Brazil, Colombia, Costa Rica, Mexico, and Thai-
land.[12] This is partly influenced by the size of the formal sector economy from which taxes
and payroll contributions can be collected. In recent decades, community-based health insur-
ance (CBHI) or “mutual health organizations” have become increasingly popular among
LMICs, particularly in Sub-Saharan Africa (e.g. Burkina Faso,[13] Senegal[14] and Rwanda
[15]) as well as Asia (e.g. China[16] and India[17]). CBHI has emerged as an alternative health
financing strategy, particularly in cases where the public sector has failed to provide adequate
access to health care.[18]
We searched for existing systematic reviews on health insurance in the Cochrane Database
for Systematic Reviews, Medline, Embase, and Econlit. Search terms “health insurance”, “low-
middle income countries”, and “utilisation” were used alongside methodological search strat-
egy to locate reviews. Seven systematic reviews were identified of varying levels of quality, [19–
26] with Acharya et al.[27] being the most comprehensive. The majority of existing reviews
has suggested that publicly-funded health insurance has typically shown a positive impact on
access to care, while the picture for financial protection was mixed, and evidence of the impact
on health status was very sparse.
This study reviews systematically the recent fast-growing evidence on the impact of health
insurance on health care utilisation, financial protection and health status in LMICs. Since the
publication of Acharya et al. (which conducted literature searches in July 2010), the empirical
evidence on the impact of health insurance has expanded significantly in terms of quantity and
quality, with growing use of sophisticated techniques to account for statistical challenges[28]
(particularly insurance selection bias). This study makes an important contribution towards
our understanding of the impact of health insurance in LMICs, taking particular care in
appraising the quality of studies. We recognise the heterogeneity of insurance schemes imple-
mented in LMICs and therefore do not attempt to generalise findings, but we aim to explore
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the pattern emerging from various studies and to extract common factors that may affect the
effectiveness of health insurance, that should be the focus of future policy and research. Fur-
thermore, we explore evidence of moral hazard in insurance membership, an aspect that was
not addressed in the Acharya et al review.[27]
Methods
This review was planned, conducted, and reported in adherence with PRISMA standards of
quality for reporting systematic reviews.[29]
Participants
Studies focusing on LMICs are included, as measured by per capita gross national income
(GNI) estimated using the World Bank Atlas method per July 2016.[30]
Intervention
Classification of health insurance can be complicated due to the many characteristics defining
its structure, including the mode of participation (compulsory or voluntary), benefit entitle-
ment, level of membership (individual or household), methods for raising funds (taxes, flat
premium, or income-based premium) and the mechanism and extent of risk pooling [31]. For
the purpose of this review, we included all health insurance schemes organised by government,
comprising social health insurance and tax-based health insurance. Private health insurance
was excluded from our review, but we recognise the presence of community-based health
insurance (CBHI) in many LMICs, especially in Africa and Asia [18]. We also therefore
included CBHI if it was scaled up nationally or was actively promoted by national government.
Primary studies that included both public and private health insurance were also considered
for inclusion if a clear distinction between the two was made in the primary paper. Studies
examining other types of financial incentives to increase the demand for healthcare services,
such as voucher schemes or cash transfers, were excluded.
Control group
In order to provide robust evidence on the effect on insurance, it is necessary to compare an
insured group with an appropriate control group. In this review, we selected studies that used
an uninsured population as the control group. Multiple comparison groups were allowed, but
an uninsured group had to be one of them.
Outcome measures
We focus on three main outcomes:
• Utilisation of health care facilities or services (e.g. immunisation coverage, number of visits,
rates of hospitalisation).
• Financial protection, as measured by changes in out-of-pocket (OOP) health expenditure at
household or individual level, and also catastrophic health expenditure or impoverishment
from medical expenses.
• Health status, as measured by morbidity and mortality rates, indicators of risk factors (e.g.
nutritional status), and self-reported health status.
The scope of this review is not restricted to any level of healthcare delivery (i.e. primary or
secondary care). All types of health services were considered in this review.
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Types of studies
The review includes randomized controlled trials, quasi-experimental studies (or “natural
experiments”[32]), and observational studies that account for selection bias due to insurance
endogeneity (i.e. bias caused by insurance decisions that are correlated with the expected level
of utilisation and/or OOP expenditure). Observational studies that did not take account of
selection bias were excluded.
Databases and search terms
A search for relevant articles was conducted on 6 September 2016 using peer-reviewed data-
bases (Medline, Embase, Econlit, CINAHL Plus via EBSCO andWeb of Science) and grey lit-
eratures (WHO, World Bank, and PAHO). Our search was restricted to studies published
since July 2010, immediately after the period covered by the earlier Acharya et al. (2012)
review. No language restrictions were applied. Full details of our search strategy are available
in the supporting information (S1 Table).
Screening and data extraction
Two independent reviewers (DE andMS) screened all titles and abstracts of the initially identified
studies to determine whether they satisfied the inclusion criteria. Any disagreement was resolved
through mutual consensus. Full texts were retrieved for the studies that met the inclusion criteria.
A data collection form was used to extract the relevant information from the included studies.
Assessment of study quality
We used the Grades of Assessment, Development and Evaluation (GRADE) system checklist
[33,34] which is commonly used for quality assessment in systematic reviews. However,
GRADE does not rate observational studies based on whether they controlled for selection
bias. Therefore, we supplemented the GRADE score with the ‘Quality of Effectiveness Esti-
mates from Non-randomised Studies’ (QuEENS) checklist.[35]
cRandomised studies were considered to have low risk of bias. Non-randomised studies
that account for selection on observable variables, such as propensity score matching (PSM),
were categorised as high risk of bias unless they provided adequate assumption checks or com-
pared the results to those from other methods, in which case they may be classed as medium
risk. Non-randomised studies that account for selection on both observables and unobserva-
bles, such as regression with difference-in-differences (DiD) or Heckman sample selection
models, were considered to have medium risk of bias–some of these studies were graded as
high or low risk depending on sufficiency of assumption checks and comparison with results
from other methods.
Heterogeneity of health insurance programmes across countries and variability in empirical
methods used across studies precluded a formal meta-analysis. We therefore conducted a nar-
rative synthesis of the literature and did not report the effect size. Throughout this review, we
only considered three possible effects: positive outcome, negative outcome, or no statistically
significant effect (here defined as p-value> 0.1).
Results
Results of the search
Our database search identified 8,755 studies. Five additional studies were retrieved from grey
literature. After screening of titles and abstracts, 118 studies were identified as potentially rele-
vant. After reviewing the full-texts, 68 studies were included in the systematic review (see Fig 1
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for the PRISMA diagram). A full description of the included studies is presented in the support-
ing information (S2 Table). Of the 68 included studies, 40 studies examined the effect on utilisa-
tion, 46 studies on financial protection, and only 12 studies on health status (see Table 1).
Utilisation of health care
Table 2 collates evidence on the effects of health insurance on utilisation of healthcare services.
Three main findings were observed:
Fig 1. PRISMA flow diagram for included and excluded studies.
https://doi.org/10.1371/journal.pone.0219731.g001
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1. Evidence on utilisation of curative care generally suggested a positive effect, with 30 out of
38 studies reporting a statistically significant positive effect.
2. Evidence on preventive care is less clear with 4 out of 7 studies reporting a positive effect,
two studies finding a negative effect and one study reporting no effect.
3. Among the higher quality studies, i.e. those that suitably controlled for selection bias
reflected by moderate or low GRADE score and low risk of bias (score = 3) on QuEENS,
seven studies reported a positive relationship between insurance and utilisation. One study
[36] reported no statistically significant effect, and another study found a statistically signif-
icant negative effect.[37]
Financial protection
Overall, evidence on the impact of health insurance on financial protection is less clear than
that for utilisation (see Table 3). 34 of the 46 studies reported the impact of health insurance
on the level of out-of-pocket health expenditure. Among those 34 studies, 17 found a positive
effect (i.e. a reduction in out-of-pocket expenditure), 15 studies found no statistically signifi-
cant effect, and two studies–from Indonesia[59] and Peru[62]–reported a negative effect (i.e.
an increase in out-of-pocket expenditure).
Another financial protection measure is the probability of incurring catastrophic health
expenditure defined as OOP exceeding a certain threshold percentage of total expenditure or
income. Of the 14 studies reporting this measure, nine reported reduction in the risk of cata-
strophic expenditure, three found no statistically significant difference, and two found a nega-
tive effect of health insurance. Only four studies reported sensitivity analysis varying changes
in the threshold level,[59,62,75,76] though this did not materially affect the findings.
Two studies used a different measure of financial protection, the probability of impoverish-
ment due to catastrophic health expenditure, reporting conflicting findings.[77,78] Finally,
four studies evaluated the effect on financial protection by assessing the impact of insurance
on non-healthcare consumption or saving behaviour, such as non-medical related con-
sumption[79], probability of financing medical bills via asset sales or borrowing[40], and
household saving[80]. No clear pattern can be observed from those four studies.
Health status
Improving health is one of the main objectives of health insurance, yet very few studies thus
far have attempted to evaluate health outcomes. We identified 12 studies, with considerable
Table 1. Summary of the impact of health insurance on utilisation, financial protection, and health outcomes.
QUEENS� score and
GRADE
Utilisation (N = 40) Financial protection† (N = 46) Health status (N = 12)
Positive
effect
No
effect
Negative
effect
Total Positive
effect
No
effect
Negative
effect
Total Positive
effect
No
effect
Negative
effect
Total
3 and Moderate 1 1 0 2 3 1 0 4 2 0 1 3
3 and Low 6 0 1 7 3 4 1 8 2 0 0 2
2 and Low 15 3 0 18 15 8 1 24 3 2 0 5
1 and Low 10 3 0 13 4 4 2 10 2 0 0 2
Total 32 7 1 40 25 17 4 46 9 2 1 12
� QUEENS score: 1 = high risk of bias; 2 = moderate risk; 3 = low risk; GRADE score: Low = low quality; Moderate = moderate quality; High = high quality
† Positive effect for financial protection means that health insurance decreases out-of-pocket health expenditure or reduces the event of catastrophic health expenditure
https://doi.org/10.1371/journal.pone.0219731.t001
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Table 2. Summary of studies reporting utilisation of health care (N = 40), by countries and year.
Study Year Country/Area Type/name of insurance� Effect QUEENS�� GRADE†
Robyn et al[13] 2012 Burkina Faso, Nouna district CBHI 0 3 Moderate
Robyn et al[38] 2012 Burkina Faso, Nouna district CBHI + 1 Low
Levine, Polimeni,
and Ramage[39]
2016 Cambodia CBHI + 3 Moderate
Babiarz et al[40] 2010 China NCMS (Voluntary) 0 2 Low
Lu, Liu, and Shen[41] 2012 China NCMS (Voluntary) + 2 Low
Chen et al[42] 2014 China URBMI (Voluntary) + 2 Low
Hou et al[43] 2014 China NCMS (Voluntary) + 2 Low
Liu and Zhao[44] 2014 China URBMI (Voluntary) + 2 Low
Cheng et al[45] 2015 China NCMS (Voluntary) + 2 Low
Liao, Gilmour,
and Shibuya[46]
2016 China All public insurance + 1 Low
Trujillo et al[47] 2010 Colombia Voluntary and subsidised scheme + 2 Low
Hassan et al[48] 2013 Colombia Subsidised scheme + 1 Low
Miller et al[49] 2013 Colombia Subsidised scheme + 3 Low
Hou and Chao[50] 2011 Georgia MIP (Subsidised scheme) + 3 Low
Zoidze et al[51] 2013 Georgia MIP (Subsidised scheme) 0 1 Low
Gotsadze et al[52] 2015 Georgia MIP (Subsidised scheme) 0 1 Low
Blanchet et al[53] 2012 Ghana NHIS (Voluntary scheme) + 1 Low
Yilma et al[54] 2012 Ghana NHIS (Voluntary scheme) + 3 Low
Abrokwah et al[55] 2014 Ghana NHIS (Voluntary scheme) + 1 Low
Brugiavini and Pace[56] 2015 Ghana NHIS (Voluntary scheme) + 2 Low
Fenny et al[57] 2015 Ghana NHIS (Voluntary scheme) + 1 Low
Sheth[37] 2014 India (Maharashtra) CBHI - 3 Low
Sood et al[58] 2014 India (Karnataka) Subsidised scheme 0 2 Low
Raza et al[36] 2016 India (Uttar Pradesh and Bihar) CBHI 0 3 Moderate
Sparrow et al[59] 2013 Indonesia JKN (Voluntary and subsidised) + 2 Low
Alkenrack and Lindelow[60] 2015 Lao PDR CBHI + 2 Low
Rivera-Hernandez et al[61] 2016 Mexico Seguro Popular (Voluntary scheme) 0 2 Low
Bernal et al[62] 2014 Peru SIS (Subsidised scheme) + 3 Low
Dhillon et al[63] 2012 Rwanda (Mayange, Mwogo and Mareba) CBHI + 1 Low
Lu et al[64] 2012 Rwanda (all rural area) CBHI + 2 Low
Panpiemras et al[65] 2011 Thailand UCS (subsidised scheme) + 1 Low
Ghislandi, Manachotphong,
and Perego[66]
2015 Thailand UCS (subsidised scheme) + 2 Low
Limwattananon et al[67] 2015 Thailand UCS (subsidised scheme) + 2 Low
Makhloufi et al[68] 2015 Tunisia MHI (Contributory) and MAS (Subsidised) + 1 Low
Nguyen[69] 2012 Vietnam All public insurance + 3 Low
Nguyen and Wang[70] 2013 Vietnam Subsidised scheme for children + 2 Low
Guindon[71] 2014 Vietnam Subsidised scheme + 2 Low
Nguyen[72] 2014 Vietnam Contributory (compulsory and voluntary) scheme + 1 Low
Palmer et al[73] 2015 Vietnam Subsidised scheme for children + 3 Low
Nguyen[74] 2016 Vietnam Voluntary and subsidised scheme (children) + 2 Low
� SHI = Social Health Insurance; CBHI = Community-based Health Insurance
�� Queens score: 1 = high risk of bias; 2 = moderate risk; 3 = low risk
† Grade score: Low = low quality; Moderate = moderate quality; High = high quality
https://doi.org/10.1371/journal.pone.0219731.t002
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Table 3. Summary of studies reporting financial protection outcome (N = 46).
Study Year Country Insurance� Cost
sharing
Effect QUEENS�� GRADE†
Parmar et al[81] 2012 Burkina Faso, Nouna
district
CBHI Yes + 2 Low
Fink et al[75] 2013 Burkina Faso, Nouna
district
CBHI Yes + 3 Moderate
Levine, Polimeni, and Ramage[39] 2016 Cambodia CBHI No + 3 Moderate
Babiarz et al[40] 2010 China NCMS (Voluntary) Yes + 2 Low
Lu, Liu, and Shen[41] 2012 China NCMS (Voluntary) Yes 0 2 Low
Cheung and Padieu[80] 2013 China NCMS (Voluntary) Yes + 2 Low
Jing et al[82] 2013 China NCMS (Voluntary) Yes 0 1 Low
Bai and Wu[79] 2014 China NCMS (Voluntary) Yes + 3 Low
Hou et al[43] 2014 China NCMS (Voluntary) Yes 0 2 Low
Liu and Zhao[44] 2014 China URBMI (Voluntary) Yes 0 2 Low
Liu, Wu, and Liu[83] 2014 China All public insurance Yes 0 1 Low
Yuan et al[84] 2014 China All public insurance Yes 0 2 Low
Atella, Brugiavini, and Pace[85] 2015 China All public insurance Yes + 1 Low
Cheng et al[86] 2015 China NCMS (Voluntary) Yes 0 2 Low
Jung and Streeter[87] 2015 China All public insurance Yes + 2 Low
Yang andWu[88] 2015 China NCMS Yes 0 2 Low
Camacho and Conover[89] 2013 Colombia Subsidised scheme No 0 3 Low
Miller et al[49] 2013 Colombia Subsidised scheme No 0 3 Low
Yilma et al[90] 2015 Ethiopia CBHI Yes + 1 Low
Zoidze et al[51] 2013 Georgia MIP (Subsidised scheme) Yes - 1 Low
Gotsadze et al[52] 2015 Georgia MIP (Subsidised scheme) Yes 0 1 Low
Abrokwah et al[55] 2014 Ghana NHIS (Voluntary scheme) Yes + 1 Low
Brugiavini and Pace[56] 2015 Ghana NHIS (Voluntary scheme) Yes 0 2 Low
Aryeetey et al[78] 2016 Ghana NHIS (Voluntary scheme) Yes + 2 Low
Fan et al[77] 2012 India (Andrha Pradesh) Subsidised scheme No + 3 Low
Sheth[37] 2014 India (Maharashtra) CBHI Yes + 3 Low
Sood et al[58] 2014 India (Karnataka) Subsidised scheme No + 2 Low
Raza et al[36] 2016 India (Uttar Pradesh and
Bihar)
CBHI Yes 0 3 Moderate
Aji et al[91] 2013 Indonesia Askeskin (Subsidised scheme) No + 2 Low
Sparrow et al[59] 2013 Indonesia Askeskin (Subsidised scheme) No - 2 Low
Alkenbrack and Lindelow[60] 2015 Lao CBHI Yes 0 2 Low
Galarraga et al[92] 2010 Mexico Seguro Popular (Voluntary scheme) Yes + 2 Low
Sosa-Rubi, Salinas-Rodriguez, and
Galarraga[93]
2011 Mexico Seguro Popular (Voluntary scheme) Yes + 2 Low
Wirtz et al[94] 2012 Mexico Seguro Popular (Voluntary scheme) Yes + 2 Low
Avilla-Burgos et al[95] 2013 Mexico Seguro Popular (Voluntary scheme) Yes + 1 Low
Grogger et al[76] 2015 Mexico All public insurance Yes + 3 Moderate
Bernal et al[62] 2014 Peru SIS (Subsidised scheme) No - 3 Low
Lu et al[64] 2012 Rwanda CBHI Yes + 2 Low
Koch and Alaba[96] 2010 South Africa Contributory scheme yes - 1 Low
Limwattananon et al[67] 2015 Thailand UCS (subsidised scheme) No + 2 Low
Makhloufi et al[68] 2015 Tunisia MHI (Contributory) and MAS
(Subsidised)
Yes 0 1 Low
Sepehri et al[97] 2011 Vietnam Contributory, voluntary, and subsidised
schemes
No + 2 Low
(Continued)
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variation in the precise health measure considered (see Table 4). There was some evidence of
positive impact on health status: nine studies found a positive effect, one study reported a neg-
ative effect, and two studies reported no effect.
Type of insurance and countries
Considering the heterogeneity of insurance schemes among different countries, we attempted
to explore the aggregate results by the type of insurance scheme and by country. Table 5 pro-
vides a summary of results classified by three type of insurance scheme: community-based
health insurance, voluntary health insurance (non-CBHI), and compulsory health insurance.
This division is based on the mode of participation (compulsory vs voluntary), which may
affect the presence of adverse selection and moral hazard. Premiums are typically community-
rated in CBHI, risk-rated in voluntary schemes and income-rated in compulsory schemes.
Table 3. (Continued)
Study Year Country Insurance� Cost
sharing
Effect QUEENS�� GRADE†
Nguyen[69] 2012 Vietnam All public insurance Yes 0 3 Low
Nguyen and Wang[70] 2013 Vietnam Subsidised scheme for children No + 2 Low
Palmer et al[73] 2015 Vietnam Subsidised scheme for children No 0 3 Low
Nguyen[74] 2016 Vietnam Voluntary and subsidised scheme
(children)
No + 2 Low
� SHI = Social Health Insurance; CBHI = Community-based Health Insurance
�� Queens score: 1 = high risk; 2 = moderate risk; 3 = low risk
† Grade score: Low = low quality; Moderate = moderate quality; High = high quality
https://doi.org/10.1371/journal.pone.0219731.t003
Table 4. Summary of studies reporting health status (N = 12).
Study Year Country Insurance� Effect QUEENS�� GRADE† Chosen outcomes
Fink et al[75] 2013 Burkina Faso, Nouna
district
CBHI - 3 Moderate Child and adult mortality
Levine, Polimeni, and
Ramage[39]
2016 Cambodia CBHI + 3 Moderate Health index
Chen and Jin[98] 2012 China NCMS (Voluntary) 0 2 Low Child and maternal mortality
Cheng et al[45] 2015 China NCMS (Voluntary) 0 2 Low Adult mortality
Peng and Conley[99] 2015 China NCMS (Voluntary) + 2 Low Malnutrition and food consumption
Camacho and Conover[89] 2013 Colombia Subsidised scheme + 3 Low Low birth weight and newborn
health status
Miller et al[49] 2013 Colombia Subsidised scheme + 3 Low Acute illness
Sood et al[58] 2014 India (Karnataka) Subsidised scheme + 2 Low Adult mortality
Pfutze[100] 2014 Mexico Seguro Popular (Voluntary
scheme)
+ 2 Low Child mortality
Pfutze[101] 2015 Mexico Seguro Popular (Voluntary
scheme)
+ 1 Low Miscarriages prevalence
Hendriks et al[102] 2014 Nigeria CBHI + 1 Low Blood pressure
Quimbo et al[103] 2011 Philippines PhilHealth (Voluntary
scheme)
+ 3 Moderate CRP-positive level and wasting
� SHI = Social Health Insurance; CBHI = Community-based Health Insurance
�� Queens score: 1 = high risk; 2 = moderate risk; 3 = low risk
† Grade score: Low = low quality; Moderate = moderate quality; High = high quality
https://doi.org/10.1371/journal.pone.0219731.t004
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In principle, CBHI is also considered a voluntary scheme, but we separated it to explore
whether the larger size of pooling from non-CBHI schemes may affect the outcomes. Social
health insurance is theoretically a mandatory scheme that requires contribution from the enro-
lees. However, in the context of LMICs, the mandatory element is hard to enforce, and in prac-
tice the scheme adopts a voluntary enrolment. Additionally, the government may also want to
subsidise the premium for poor people. Therefore, in this review SHI schemes can fall into
either the voluntary health insurance (non-CBHI) or compulsory health insurance (non-
CBHI), depending on the target population defined in the evaluation study. Lastly, we chose
studies with high quality/low risk only to provide more robust results.
Based on the summary in Table 5, the effect on utilisation overall does not differ based on
type of insurance, with most evidence suggesting an overall increase in utilisation by the
insured. The two studies showing no effect or reduced consumption of care were conducted in
two different areas of India, which may–somewhat tentatively–suggest a common factor
Table 5. Summary of results based on type of insurance, only 18 studies with high quality and low risk of bias.
Country and type of insurance
scheme
Summary
Community-based health insurance/
CBHI (N = 5 studies)
Overall: positive effect on utilisation but two studies from India shows no
positive effect. Positive effect on financial protection but not in India.
Contentious effect on health status
1. Burkina Faso Positive effect on utilisation [38], reduced catastrophic health expenditure
events, but negative effect on elderly’s health,� 65 years old.[75] No effect
among adults< 65 years old and children.[75]
2. Cambodia Positive effect on utilisation, reduced OOP health expenditure, but no
effect on health status [39]
3. India Reduced consumption of health care but the author argued it could be that
the enrolees were becoming healthier reducing their need to seek care.[37]
Another paper shows no effect on utilisation and OOP health expenditure
[36]
Voluntary health insurance, non-CBHI
(N = 7 studies)
Overall: positive effect on utilisation. Inconclusive on financial protection,
but there is an indication it is affected by rurality and proximity to
adequately-staffed health facilities. Positive effect on specific health status,
but not mortality rate.
1. Ghana Positive effect on utilisation [54]
2. Vietnam Positive effect on utilisation but no effect on OOP health expenditure [69]
3. Mexico Reduced health expenditure among enrolees living in rural area and
proximate to large health facilities. Similar effect among the enrolees living
in urban area [76]
4. Philippines Positive effect on health status measured by wasting and C-reactive
protein level [103]
5. China Positive effect on utilisation among the elderly enrolees (>65 years old)
[45]; no effect on OOP health expenditure [45] but reduced non-medical
consumption among the enrolees[79]; No effect on mortality rate [45,98]
Compulsory health insurance, non-
CBHI
(N = 6 studies)
Overall: positive effect on utilisation. Inconclusive evidence on financial
protection, positive effect on specific health status.
1. India Reduced OOP health expenditure for inpatient care [77]
2. Vietnam Positive effect on utilisation but not on OOP health expenditure [73]
3. Georgia Positive effect on utilisation [50]
4. Peru Positive effect on utilisation of preventive and curative care, but negative
effect on OOP health expenditure [62]
5. Colombia Positive effect on utilisation and reduced OOP health expenditure [49]
Positive effect on newborn health measured by incidence of low birth
weight and several indicators of preterm baby [89]
https://doi.org/10.1371/journal.pone.0219731.t005
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unique to India’s health system that may compromise the effectiveness of health insurance in
increasing utilisation.
Regarding financial protection, the evidence for both CBHI and non-CBHI voluntary
health insurance is inconclusive. Furthermore, there is an indication of heterogeneity by sup-
ply side factors captured by proximity to health facilities. Evidence from studies exploring sub-
sidised schemes suggests no effect on financial protection, even a negative effect among the
insured in Peru.
Lastly, evidence for health status may be influenced by how health outcomes are measured.
Studies exploring specific health status, (examples included health indexes, wasting, C-reactive pro-
tein, and low birth weight), show a positive effect, whereas studies using mortality rates tends to
show no effect or even negative effects. Studies exploring CBHI scheme did not find any evidence
of positive effect on health status, as measured either by mortality rate or specific health status.
Discussion
This review synthesises the recent, burgeoning empirical literature on the impact of health
insurance in LMICs. We identified a total of 68 eligible studies over a period of six years–dou-
ble the amount identified by the previous review by Acharya et al. over an approximately
60-year time horizon (1950—July 2010). We used two quality assessment checklists to scruti-
nise the study methodology, taking more explicit account of the methodological robustness of
non-experimental designs.
Programme evaluation has been of interest to many researchers for reporting on the effec-
tiveness of a public policy to policymakers. In theory, the gold standard for a programme eval-
uation is the randomised control trial, in which the treatment is randomly assigned to the
participants. The treatment assignment process has to be exogenous to ensure that any
observed effect between the treated and control groups can only be caused by the difference in
the treatment assignment. Unfortunately, this ideal scenario is often not feasible in a public
policy setting. Our findings showed that only three papers between 2010 and 2016 were able to
conduct a randomised study to evaluate the impact of health insurance programmes in devel-
oping countries, particularly CBHI [38,75,103]. Policymakers may believe in the value of an
intervention regardless of its actual evidence base, or they may believe that the intervention is
beneficial and that no one in need should be denied it. In addition, policymakers are inclined
to demonstrate the effectiveness of an intervention that they want implemented in the most
promising contexts, as opposed to random allocation [104].
Consequently, programme evaluators often have to deal with a non-randomised treatment
assignment which may result in selection bias problems. Selection bias is defined as a spurious
relationship between the treatment and the outcome of interest due to the systematic differ-
ences between the treated and the control groups [105]. In the case of health insurance, an
individual who chooses to enrol in the scheme may have different characteristics to an individ-
ual who chooses not to enrol. When those important characteristics are unobservable, the ana-
lyst needs to apply more advanced techniques and, sometimes, stronger assumptions. Based
on our findings, we noted several popular methods, including propensity score matching
(N = 8), difference-in-difference (N = 10), fixed or random effects of panel data (N = 6), instru-
mental variables (N = 12) and regression discontinuity (N = 6). Those methods have varying
degree of success in controlling the unobserved selection bias and analysts should explore the
robustness of their findings by comparing initial findings with other methods by testing
important assumptions. We noted some papers combining two common methods, such as dif-
ference-in-difference with propensity score matching (N = 10) and fixed effects with instru-
mental variables (N = 8), in order to obtain more robust results.
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Overall effect
Compared with the earlier review, our study has found stronger and more consistent evidence
of positive effects of health insurance on health care utilisation, but less clear evidence on
financial protection. Restricting the evidence base to the small subset of randomised studies,
the effects on financial protection appear more consistently positive, i.e. three cluster rando-
mised studies[39,75,76] showed a decline in OOP expenditure and one randomised study[36]
found no significant effect.
Besides the impact on utilisation and financial protection, this review identified a number
of good quality studies measuring the impact of health insurance on health outcomes. Twelve
studies were identified (i.e. twice as many as those published before 2010), nine of which
showed a beneficial health effect. This holds for the subset of papers with stronger methodol-
ogy for tackling selection bias.[39,49,89,103] In cases where a health insurance programme
does not have a positive effect on either utilisation, financial protection, and health status, it is
particularly important to understand the underlying reasons.
Possible explanation of heterogeneity
Payment system. Heterogeneity of the impact of health insurance may be explained by
differences in health systems and/or health insurance programmes. Robyn et al. (2012) and
Fink et al (2013) argued that the lack of significant effect of insurance in Burkina Faso may
have been partially influenced by the capitation payment system. As the health workers relied
heavily on user fees for their income, the change of payment system from fee-for-services to
capitation may have discouraged provision of high quality services. If enrolees perceive the
quality of contracted providers as bad, they might delay seeking treatment, which in turn
could impact negatively on health.
Several studies from China found the utilisation of expensive treatment and higher-level
health care facilities to have increased following the introduction of the insurance scheme.
[41,44,45,88] A fee-for-service payment system may have incentivised providers to include
more expensive treatments.[43,83,88] Recent systematic reviews suggested that payment sys-
tems might play a key role in determining the success of insurance schemes,[23,106] but this
evidence is still weak, as most of the included studies were observational studies that did not
control sufficiently for selection bias.
Uncovered essential items. Sood et al. (2014) found no statistically significant effect of
community-based health insurance on utilisation in India. They argued that this could be
caused by their inability to specify the medical conditions covered by the insurance, causing
dilution of a potential true effect. In other countries, transportation costs[69] and treatments
that were not covered by the insurance[59,60] may explain the absence of a reduction in out-
of-pocket health expenditures.
Methodological differences. Two studies in Georgia evaluated the same programme but
with different conclusions.[50,51] This discrepancy may be explained by the difference in the
estimated treatment effect: one used average treatment effect (ATE), finding no effect, and
another used average treatment effect on the treated (ATT), reporting a positive effect. ATE is
of prime interest when policymakers are interested in scaling up the programme, whereas
ATT is useful to measure the effect on people who were actually exposed to insurance.[107]
Duration of health insurance. We also found that the longer an insurance programme
has been in place prior to the timing of the evaluation, the higher the odds of improved health
outcomes. It is plausible that health insurance would not change the health status of population
instantly upon implementation.[21] While there may be an appetite among policymakers to
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obtain favourable short term assessments, it is important to compare the impact over time,
where feasible.
Moral hazard. Acharya et al (2012) raised an important question about the possibility of a
moral hazard effect as an unintended consequence of introducing (or expanding) health insur-
ance in LMICs. We found seven studies exploring ex-ante moral hazard by estimating the
effect on preventive care. If uninsured individuals expect to be covered in the future, they may
reduce the consumption of preventive care or invest less in healthy behaviours.[108,109] Cur-
rent overall evidence cannot suggest a definite conclusion considering the heterogeneity in
chosen outcomes. One study found that the use of a self-treated bed nets to prevent malaria
declined among the insured group in Ghana[54] while two studies reported an increase in vac-
cination rates[62] and the number of prenatal care visits[55,62]among the insured group.
Another study reported no evidence that health insurance encouraged unhealthy behaviour or
reduction of preventive efforts in Thailand.[66]
Two studies from Colombia found that the insured group is more likely to increase their
demand for preventive treatment.[47,49] As preventive treatment is free for all, both authors
attributed this increased demand to the scheme’s capitation system, incentivising providers to
promote preventive care to avoid future costly treatments.[110] Another study of a different
health insurance programme in Colombia found an opposite effect.[48]
Study limitations. This review includes a large variety of study designs and indicators for
assessing the multiple potential impacts of health insurance, making it hard to directly com-
pare and aggregate findings. For those studies that used a control group, the use of self-selected
controls in many cases creates potential bias. Studies of the effect of CBHI are often better at
establishing the counterfactual by allowing the use of randomisation in a small area, whereas
government schemes or social health insurance covering larger populations have limited
opportunity to use randomisation. Non-randomised studies are more susceptible to confound-
ing factors unobserved by the analysts. For a better understanding of the links between health
insurance and relevant outcomes, there is also a need to go beyond quantitative evidence alone
and combine the quantitative findings with qualitative insights. This is particularly important
when trying to interpret some of the counterintuitive results encountered in some studies.
Conclusion
The impact of different health insurance schemes in many countries on utilisation generally
shows a positive effect. This is aligned with the supply-demand theory in whichhealth insur-
ance decreases the price of health care services resulting in increased demand. It is difficult to
draw an overall conclusion about the impact of health insurance on financial protection, most
likely because of differences in health insurance programmes. The impact of health insurance
on health status suggests a promising positive effect, but more studies from different countries
is required.
The interest in achieving UHC via publicly funded health insurance is likely to increase
even further in the coming years, and it is one of the United Nation’s Sustainable Development
Goals (SDGs) for 2030[111]. As public health insurance is still being widely implemented in
many LMICs, the findings from this review should be of interest to health experts and policy-
makers at the national and the international level.
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